Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
Core EBITDA Growth

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 12.5759.64-14.83-17.6213.02

What is the latest Core EBITDA Growth ratio of AUROBINDO PHARMA ?

The latest Core EBITDA Growth ratio of AUROBINDO PHARMA is 12.57 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202512.57
Mar202459.64
Mar2023-14.83
Mar2022-17.62
Mar202113.02

How is Core EBITDA Growth of AUROBINDO PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 12.57
-78.92
Mar2024 59.64
Positive
Mar2023 -14.83
Negative
Mar2022 -17.62
Negative
Mar2021 13.02 -

Other Financial Ratios of AUROBINDO PHARMA


Compare Core EBITDA Growth ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹70,181.0 Cr -1.1% 9.9% -1.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,566.0 Cr 1.2% 5.3% 0.9% Stock Analytics
DIVIS LABORATORIES ₹171,594.0 Cr -0.7% -2.1% 12.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹125,826.0 Cr -3.2% 4.1% 20.2% Stock Analytics
CIPLA ₹123,504.0 Cr -0.2% -6.7% 1.8% Stock Analytics
DR REDDYS LABORATORIES ₹104,132.0 Cr 0.2% -2.7% 2% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-1.1%

9.9%

-1.2%

SENSEX

1.4%

2%

10.2%


You may also like the below Video Courses